SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Joshua T. Cohen · Study

Home/Author

Joshua T. Cohen

15 works· latest 2020· 3 institutionscluster: provisionalORCID 0000-0003-1737-0991

h-index15

i1015

Citations3,941

Works here15

96

05

09

10

12

14

15

16

17

18

20

Most cited in this library

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold2014 · 2,247 citations
Perspective and Costing in Cost-Effectiveness Analysis, 1974–20182020 · 279 citations
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies2018 · 168 citations
QALYs in 2018—Advantages and Concerns2018 · 155 citations
Measuring the Value of Prescription Drugs2015 · 144 citations

Works

15 shown

Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018

PharmacoEconomics·2020·6 authors·Open access

279citations

QALYs in 2018—Advantages and Concerns

JAMA·2018·2 authors

155citations

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies

Value in Health·2018·4 authors·Open access

168citations

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs

PLoS Medicine·2017·6 authors·Open access

103citations

The influence of time horizon on results of cost-effectiveness analyses

Expert Review of Pharmacoeconomics & Outcomes Research·2017·6 authors

103citations

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted

PLoS ONE·2016·8 authors

·review

·Open access

92citations

Measuring the Value of Prescription Drugs

New England Journal of Medicine·2015·2 authors

144citations

The Changing Face of the Cost-Utility Literature, 1990–2012

Value in Health·2015·5 authors·Open access

103citations

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

New England Journal of Medicine·2014·3 authors

2,247citations

Toward modernizing the systematic review pipeline in genetics: efficient updating via data mining

Genetics in Medicine·2012·9 authors·review·Open access

62citations

Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents

Health Economics·2010·6 authors

141citations

Much Cheaper, Almost as Good: Decrementally Cost-Effective Medical Innovation

Annals of Internal Medicine·2009·3 authors·review

92citations

30 Years of Pharmaceutical Cost-Utility Analyses

PharmacoEconomics·2009·2 authors

78citations

When Is Evidence Sufficient?

Health Affairs·2005·3 authors

97citations

The use of two‐stage Monte Carlo simulation techniques to characterize variability and uncertainty in risk analysis

Human and Ecological Risk Assessment An International Journal·1996·3 authors

77citations